Robeco Institutional Asset Management B.V. lifted its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 141.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 575,055 shares of the health services provider's stock after acquiring an additional 337,305 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.34% of Teladoc Health worth $5,279,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Clearline Capital LP increased its holdings in shares of Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock worth $42,682,000 after purchasing an additional 3,483,665 shares during the period. The Manufacturers Life Insurance Company increased its stake in Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock worth $932,000 after acquiring an additional 63,028 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Teladoc Health by 74.0% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider's stock valued at $311,000 after acquiring an additional 8,750 shares in the last quarter. Mackenzie Financial Corp raised its holdings in Teladoc Health by 170.7% in the 2nd quarter. Mackenzie Financial Corp now owns 107,255 shares of the health services provider's stock valued at $1,049,000 after acquiring an additional 67,640 shares in the last quarter. Finally, Janney Montgomery Scott LLC lifted its position in shares of Teladoc Health by 188.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider's stock valued at $477,000 after acquiring an additional 20,651 shares during the period. 76.82% of the stock is owned by institutional investors.
Teladoc Health Stock Down 2.9 %
TDOC stock traded down $0.28 during trading on Friday, reaching $9.23. 3,857,162 shares of the stock were exchanged, compared to its average volume of 5,498,724. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $22.54. The firm's 50 day moving average is $8.69 and its 200 day moving average is $9.55. The firm has a market cap of $1.59 billion, a P/E ratio of -1.60 and a beta of 0.90.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, research analysts forecast that Teladoc Health, Inc. will post -1.19 EPS for the current year.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. JPMorgan Chase & Co. dropped their price target on Teladoc Health from $16.00 to $9.00 and set a "neutral" rating for the company in a research note on Monday, August 26th. Canaccord Genuity Group cut their price target on shares of Teladoc Health from $25.00 to $17.00 and set a "buy" rating for the company in a report on Thursday, August 1st. Stifel Nicolaus decreased their price objective on shares of Teladoc Health from $16.00 to $9.00 and set a "hold" rating on the stock in a research note on Thursday, August 1st. Truist Financial lowered their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a research report on Friday, August 2nd. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, August 1st. Fourteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and a consensus price target of $11.97.
Read Our Latest Research Report on Teladoc Health
Insider Activity
In related news, Director Thomas Mckinley purchased 4,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $7.69 per share, with a total value of $30,760.00. Following the transaction, the director now owns 39,077 shares of the company's stock, valued at $300,502.13. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Mala Murthy sold 8,750 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the sale, the chief financial officer now directly owns 85,767 shares of the company's stock, valued at approximately $614,091.72. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas Mckinley acquired 4,000 shares of the business's stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the transaction, the director now owns 39,077 shares of the company's stock, valued at approximately $300,502.13. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders have sold 20,051 shares of company stock worth $143,565 over the last 90 days. 0.95% of the stock is currently owned by corporate insiders.
Teladoc Health Company Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.